In this paper we demonstrate that modulator sequences upstream of the enhancer of the major immediateearly promoter of human cytomegalovirus exert a differential effect on the level of transcription in a variety of cells and that this region has the capacity to interact with specific nuclear protein. Depending on the cell type, these modulator sequences increased or decreased transcriptional activation from the IEl gene promoterenhancer. The cell lines identified in this report should be useful to study the molecular mechanism of cell-specific transcriptional repression and activation exerted by the major immediate-early promoter upstream region.
Although human cytomegalovirus (HCMV) nonproductively infects cells of many types from humans (8, 16, 17) and other species (2, 11) , the virus replicates in vitro only in fibroblasts of human origin. Transcription of the first viral genes expressed, the immediate-early (IE) genes, are mainly dependent on host cell factors (1, 5-7, 20, 21) , suggesting that this may constitute the primary event at which expression of the viral genome is regulated. Regulatory sequences of the HCMV major IE gene, the IEl gene, encompass a polymerase II promoter between +1 and -65 (6, 19) ; a strong and complex enhancer between -66 and -524 (1, 5, 7), which is active in many different cell types; a cluster of nuclear factor 1-binding sites between -600 and -720 (9, 10) ; and modulator sequences between -750 and -1145 (14, 15) . These modulator sequences negatively regulate expression in nonpermissive undifferentiated teratocarcinoma (Tera-2) cells but positively influence expression in permissive differentiated cells (14, 15) . In the present study we have addressed the question of whether the modulator region is functional in cell types other than the embryonal carcinoma cell system and whether indeed it may contribute to cellspecific expression.
Recombinant plasmids containing the modulator (A1145) or with the modulator sequences truncated (A525), which were previously used to define the modulator region (15) , were analyzed for transcriptional activity by transient-transfection experiments in a variety of cells. Monolayer cells (SW480 and 293) were transfected by the calcium phosphate technique (15) , and nonadherent cells (H9, Jurkat, Namalwa, Raji, and U937) were transfected by the DEAE-dextran chloroquine technique. Approximately 107 cells were cotransfected with 30 ,ug of the respective plasmid and 5 ,ug of the transfected control plasmid pRSVL, a plasmid containing the luciferase gene under the control of the Rous sarcoma virus long terminal repeat (LTR) (3). Cells were harvested after 48 h, and protein reporter functions were assayed as described previously (15) . The relative chloramphenicol acetyltransferase (CAT) activities directed by plasmids A1145 and A525 in cells of various lineages were measured by scintillation counting of conversion rates from chloramphenicol to its acetylated forms. All cells were cotransfected with pRSV-luciferase as a transfection control (3) , and the results with A1145 and A525 were adjusted according to the relative luciferase activity in the cell extracts. The effect of the modulator sequences on CAT activity differed depending on cell type (Fig. 1) . A twofold negative effect was observed in H9, U937, and SW480 cells, but expression in Jurkat, 293, Raji, and Namalwa cells was barely affected. In B cells the expression was augmented about three-to fourfold by the upstream sequences. These results clearly indicate that the HCMV modulator sequences can influence IE promoterenhancer activity in vivo in cell types other than teratocarcinoma cells. In particular, the cis-acting sequences negatively modulate expression in some T cells and rectal epithelial cells, in which HCMV is found during natural infection.
To identify functional properties of this region in vitro, we analyzed transcriptional activities of IE1 promoter-enhancer templates, with or without the upstream sequences, in nuclear extracts from a variety of cell lines. Nuclear extracts were prepared from nuclei (2 x 109 to 5 x 109) of Jurkat, CEM, H9, U937, Raji, Epstein-Barr virus-transformed B cells, T47-D, HeLa S3, and 293 cells essentially as described previously (4) . Figure 2A shows runoff transcription products from templates A1145 and A524 with nuclear extracts from the various cell types. Conditions for in vitro transcription were as previously described (5), except that a 30-,ul reaction volume was used which included 300 ,M CTP, GTP, and ATP and 70 ,ug of nuclear protein. Although the transcriptional efficiencies in nuclear extracts from each cell line varied among preparations, the relative number of transcriptions of A1145 to A524 in each cell line were similar. Greatly reduced transcriptional activity from A1145 was observed in nuclear extracts from CEM, U937, and Raji cells. Slightly lower levels of repression were detected in HeLa S3 and H9 cells, whereas extracts from Jurkat, 293, T47-D, and B cells exerted only a marginal effect.
To assess the extent of specificity of the cell-specific transcriptional modulation for the HCMV IE1 promoter, we performed control experiments and analyzed transcription from two human immunodeficiency virus (HIV) LTR templates. The HIV LTR has been shown in vivo (18) and in vitro (13) to contain a negative transcriptional-regulatory element upstream of -278. In nuclear extracts from CEM, Raji, T47-D, and B cells, the relative transcriptional activities of HIV templates with deletion endpoints at -453 and -278 (Fig. 3B) were significantly different from those obtained with the two IEl templates (Fig. 2B ). This suggests that the negative regulatory element in the HIV LTR is different from that in the IEl gene. Similar to the IEl template A1145, the HIV template A453 showed transcriptional inhibition in H9 and U937 extracts. In general, the observed in vivo modulatory effect correlated well with the in vitro experiments. However, it should be noted that the in vitro experiments involve the use of naked DNA templates with a subfraction of soluble nuclear factors. Also, they do no exclude the possibility that other sequences have additional effects. For example, A524 but not A1145 contains 50-base-pair IEl RNA-encoding sequences which may stimulate IEl gene expression in tissue culture cells. Therefore, such assays may only be a partial reflection of the functional aspects of a specific region.
Since the activities of the modulator region may be mediated by the binding of transcription factors, we have further investigated the ability of this region to interact with nuclear proteins. Initially, HeLa S3 cells nuclear extract was chosen because of its ability to repress in vitro transcription from templates containing the modulator region. In an electrophoretic mobility shift analysis, the PstI-AluI fragment from -1145 to -773 and nuclear proteins formed one major and several minor complexes ( Fig. 4A, lane 2 (Fig. 4A, lanes 6 and 7) . It is possible that the proteins forming complex c recognize similar sequence structures in the promoter and upstream regions or that such factor(s) recognize more than one sequence. On the basis of results from binding assays with smaller and overlapping restriction fragments, sequences between -970 and -912 participate in the formation of complex c (data not shown).
To determine whether nucleoprotein complexes were specific to HeLa cell nuclear proteins, we analyzed binding to the modulatory region by using the library of transcriptionally active nuclear extracts. Nuclear proteins from T cells (Jurkat, CEM, and H9), monocytes (U937), Burkitt lymphoma cells (Raji), Epstein-Barr virus-immortalized B cells, mammary epithelial cells (T47-D), and embryonic kidney cells (293) induced the formation of complexes (Fig. 4B) with similar mobilities to those found in the HeLa cell nuclear extract. An additional complex with a mobility greater than that of complex a, but less than that of complex b, was observed predominantly in the nuclear extract from T47-D cells and to a lesser extent in extracts from Jurkat and U937 cells (Fig. 4B, lanes 8, 3, efficiencies in each tested extract, suggesting that this modulator region is a target for related DNA-binding proteins which are present in all cell types.
Proteins from each of the transcriptionally active nuclear extracts formed generally similar patterns of protein-DNA complexes with the modulator region in the mobility shift assay; we did not observe a simple correlation between the transcriptional activities and protein binding. This could reflect the inability of the mobility shift assay to resolve complexes containing similar and/or posttranslationally modified proteins. Alternatively, the activity of this region could be dependent on transcription factors acting through protein-protein interactions and may not necessarily be detected in this assay. We also cannot exclude the possibility that enhancer and promoter sequences absent in the binding assay are required for the stability of a complex associated with the modulator region. It has been suggested that nuclear factor 1-binding sites between -775 and -665 might be involved in the modulator activities (10, 12, 14, 15 
